Dr Campos is based in Boston, Massachusetts, where she is Director of Clinical Pathways and Educational Initiatives for the Division of Gynecologic Oncology at the Dana-Farber Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School. Her primary clinical responsibilities include supervising and coordinating the care of patients with ovarian, endometrial, and uterine malignancies, as well as mentoring more junior physicians. Dr Campos’ research interests focus on the clinical application of novel therapies in gynecological cancers, and she is principal investigator for several ongoing clinical trials. In addition, she participates in the Uterine Task Force of the National Cancer Institute (NCI) Gynecologic Cancer Steering Committee. As well as her involvement with the NCI, Dr Campos serves on several national and international boards, including the National Comprehensive Cancer Network Uterine Cancer Committee and the Gynecology Oncology Group Corpus Committee. She is also a member of various professional societies and a previous Chair of the American Society of Clinical Oncology Gynecological Education Committee. Dr Campos is highly published, having authored many peer-reviewed articles, clinical guidelines, and educational texts. She also serves as an Editor or consultant for several peer-reviewed journals, including the Journal of Clinical Oncology and Gynecologic Oncology.